John Olsen
About John Olsen
John Olsen is a Senior Research Associate II at Kite Pharma, where he focuses on the data-driven qualification of cell therapy products. He holds a Bachelor of Science in Biology from Hofstra University and has expertise in chimeric antigen receptors and viral vector development.
Work at Kite Pharma
John Olsen serves as a Senior Research Associate II at Kite Pharma, Inc., where he has been employed since 2016. His role focuses on the data-driven qualification of cell therapy products. He contributes to the advancement of innovative therapies by applying his expertise in experimental design and data analysis within the field of molecular biology.
Education and Expertise
John Olsen earned a Bachelor of Science (BS) degree in Biology from Hofstra University, completing his studies from 2009 to 2012. His academic background has equipped him with a strong foundation in biological sciences, which he applies in his current research. He specializes in the expression and study of chimeric antigen receptors (CARs) in primary T-cells and cell lines.
Background
Prior to his tenure at Kite Pharma, John Olsen worked as a Research Technician at Winthrop-University Hospital from 2012 to 2015. This experience provided him with valuable skills and knowledge in research methodologies, particularly in molecular biology. His work at the hospital laid the groundwork for his current focus on cell therapy and gene editing.
Research Contributions
John Olsen is involved in the development and production of viral vectors for gene editing and epigenetic studies. His contributions are significant in the context of advancing cell therapies, particularly through his work with chimeric antigen receptors. His expertise in experimental design enhances the efficacy of research projects within his team.